We are live on ! Find out more
TLSA icon

Tiziana Life Sciences

23 hedge funds and large institutions have $5.63M invested in Tiziana Life Sciences in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

176% more capital invested

Capital invested by funds: $2.04M → $5.63M (+$3.59M)

5.26% more ownership

Funds ownership: 0.72%5.98% (+5.3%)

0% more funds holding

Funds holding: 2323 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
23
Holders Change
Holders Change %
0%
% of All Funds
0.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
4
Reduced
4
Closed
11
Calls
$15K
Puts
Net Calls
+$15K
Net Calls Change
-$42K
Name Holding Trade Value Shares
Change
Change in
Stake
CG
26
Cutler Group
California
-$1K -1,000 Closed
Wells Fargo
27
Wells Fargo
California
-$1K -1,000 Closed
SWM
28
Spire Wealth Management
Virginia
-$1K -750 Closed
Osaic Holdings
29
Osaic Holdings
Arizona
+$7 +5 New
US Bancorp
30
US Bancorp
Minnesota
+$663 +500 New

TLSA Hedge Fund Activity: Q4 2021 in Review

23 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q4 2021, worth a combined $5.63M — up 176% from $2.04M a quarter earlier.

Fund positioning in TLSA was balanced in Q4 2021: 11 funds opened new positions, 11 closed out, 4 added to existing stakes and 4 trimmed.

The largest buyer was HighTower Advisors, opening a new position worth an estimated $5.48M. The largest seller was BlackRock, cutting an estimated $689K.

  • 23 institutional investors held Tiziana Life Sciences (TLSA) as of Q4 2021, unchanged from Q3 2021.
  • Funds reported $5.63M of Tiziana Life Sciences stock for Q4 2021, up 176% quarter-over-quarter.
  • 11 funds opened new Tiziana Life Sciences positions in Q4 2021 and 11 closed out, a net change of 0 holders.
  • The largest Tiziana Life Sciences buyer in Q4 2021 was HighTower Advisors, an estimated $5.48M added.
  • The largest Tiziana Life Sciences seller in Q4 2021 was BlackRock, an estimated $689K sold.

Based on aggregated 13F filings for Q4 2021.